| Patents for C07D 217 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems (11,865) |
|---|
| 03/18/2003 | US6534650 Benzisoxazole and 4-amidino-3-hydroxyphenyl chemical intermediates |
| 03/18/2003 | US6534522 Subtype-selective NMDA receptor ligands and the use thereof |
| 03/18/2003 | US6534520 Antiviral compounds |
| 03/18/2003 | US6534503 Melanocortin receptor-3 ligands to treat sexual dysfunction |
| 03/18/2003 | US6534499 For therapy of autoimmune disease |
| 03/13/2003 | WO2002036554A3 Amidino-urea serotonin receptor ligands and compositions, their pharmaceutical uses, and methods for their snythesis |
| 03/12/2003 | WO2002024654A1 Amino heterocyclic compounds (factor xa inhibitors 14) |
| 03/12/2003 | EP1289958A2 BENZOPHENONES AS INHIBITORS OF IL-1$g(b) AND TNF-$g(a) |
| 03/12/2003 | EP1289935A1 Excitatory amino acid receptor modulators |
| 03/12/2003 | EP0975601B1 Process for making a butylthio-isoquinoline and intermediates therefor |
| 03/12/2003 | EP0789577B1 Synthesis of n-substituted oligomers |
| 03/12/2003 | CN1402712A Novel heterocyclic compounds and salts thereof and medicinal use of same |
| 03/12/2003 | CA2422067A1 Aminoheterocycles (factor xa inhibitors 14) |
| 03/11/2003 | US6531599 Compounds having activity as inhibitors of cytochrome P450RAI |
| 03/11/2003 | US6531485 Prostaglandin agonists |
| 03/11/2003 | CA2254117C 2,4-diaminopyrimidine derivatives |
| 03/06/2003 | WO2003018017A1 3-substituted 6,7-dihydroxytetrahydroisoquinoline derivatives for use as antibacterial agents |
| 03/06/2003 | WO2003017764A1 Substituted propargylamines |
| 03/06/2003 | WO2002100844A3 Hiv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis |
| 03/06/2003 | WO2002024672A3 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases |
| 03/06/2003 | WO2002004423A8 Thrombin inhibitors comprising an aminoisoquinoline group |
| 03/06/2003 | CA2458477A1 3-substituted 6,7-dihydroxytetrahydroisoquinoline derivatives for use as antibacterial agents |
| 03/05/2003 | EP1288203A1 Cyclic nitrones and pharmaceutical compositions containing them |
| 03/05/2003 | EP1288202A1 N-acyltetrahydroisoquinoline derivatives |
| 03/05/2003 | EP1286994A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity |
| 03/05/2003 | EP1286978A1 Cyclohexyl derivatives and their use as therapeutic agents |
| 03/05/2003 | EP1286967A1 Cyclohexane derivatives and their use as therapeutic agents |
| 03/05/2003 | EP0832069B1 BIPHENYL-2-CARBOXYLIC ACID-TETRAHYDRO-ISOQUINOLIN-6-YL AMIDE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS INHIBITORS OF MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN AND/OR APOLIPOPROTEIN B (Apo B) SECRETION |
| 03/05/2003 | CN1400505A Image forming material and ammonium compound |
| 03/05/2003 | CN1102561C Method of resolving racemic mixtures |
| 03/04/2003 | US6528687 Hydrogenation of an imine in the presence of a base and, a ruthenium complex of a chiral diphosphine and diamine catalyst |
| 03/04/2003 | US6528649 Imidazoloisoquinolines |
| 03/04/2003 | US6528532 Benzenesulfonamide group |
| 03/04/2003 | US6528508 A bicyclic nitrogen containing heteroaromatic compound useful for inhibiting protein kinase p38 which involved in cell proliferation, cell death and response to extracellular stimuli |
| 02/27/2003 | WO2003000181A3 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 02/27/2003 | WO2002089749A3 Arylsulfonamide ethers, and methods of use thereof |
| 02/27/2003 | WO2002086878A3 Optical data carrier whose information layer contains a light-absorbing compound having a number of chromophoric centers |
| 02/27/2003 | US20030040633 Useful for therapy of HIV-related diseases based on its inhibitory action on proteases derived from viruses |
| 02/26/2003 | EP1284967A1 3-substituted isoquinolin-1-yl derivatives |
| 02/26/2003 | EP1284966A2 Process for the synthesis of amine ethers from secondary amino oxides |
| 02/26/2003 | EP1284734A1 Protein kinase inhibitors |
| 02/26/2003 | EP1112456B1 Tube for lining pipes and channels, and a method and device for the production thereof |
| 02/26/2003 | CN1399537A Composition for dyeing keratnous fibres containing 3-amino pyrazolo-[1,5-A]-pyridines, dyeing method, novel 3-amino pyrazolo-[1,5-A]-pyridines |
| 02/26/2003 | CN1398854A New iso quinoline compound with HIV-1 resisting activity |
| 02/25/2003 | US6525215 HIV protease inhibitors |
| 02/25/2003 | US6525077 Cyanoguanidine prodrugs |
| 02/25/2003 | US6525068 Hydronaphtalene compounds, prepared by a rhodium catalyzed ring opening reaction in the presence of phosphine ligand |
| 02/25/2003 | US6525042 Sulfonyl derivatives |
| 02/25/2003 | US6525036 Compounds and compositions as protease inhibitors |
| 02/25/2003 | US6525025 Controlling apoptosis; cardiovascular disorders; central nervous system disorders |
| 02/20/2003 | WO2003014089A1 Aminotetrahydroisoquinoline derivatives as analgesics |
| 02/20/2003 | WO2003014072A1 Disulfide and thiosulfonate ligands and libraries comprising these ligands |
| 02/20/2003 | WO2003013545A1 Novel benzo-fused heterocycles as endothelin antagonisits |
| 02/20/2003 | WO2002049993A3 High affinity small molecule c5a receptor modulators |
| 02/20/2003 | WO2002024635A3 Aminoalcohol derivatives |
| 02/20/2003 | US20030036551 Aryl or heteroaryl-substituted tetrahydroisoquinoline derivates possess anti-convulsant activity and are therefore believed to be useful in the treatment and/or prevention of many diseases |
| 02/20/2003 | US20030036550 Beta3-adrenoreceptor agonists, agonist compositions and methods of making and using the same |
| 02/20/2003 | CA2457814A1 Disulfide and thiosulfonate ligands and libraries comprising these ligands |
| 02/20/2003 | CA2454417A1 Novel benzo-fused heterocycles as endothelin antagonists |
| 02/19/2003 | EP1284140A2 Use of ritonavir (ABT-538) for improving the pharmacokinetics of drugs metabolized by cytochrome P450 in a method of treating aids |
| 02/19/2003 | EP1283827A2 Caspase inhibitors and uses thereof |
| 02/19/2003 | EP1283711A1 Peptide deformylase inhibitors |
| 02/19/2003 | EP0920429B1 Substituted pyrido- or pyrimido-containing 6,6- or 6,7-bicyclic derivatives |
| 02/19/2003 | EP0917530B1 Tetrahydroisoquinoline derivatives as modulators of dopamine d3 receptors |
| 02/19/2003 | EP0774969B1 Hiv protease inhibitor combination |
| 02/19/2003 | CN1101815C 3-aminochromanylsulfonyl (thio) ureas, processes for their prepn. their use, and pharmaceutical prepn. comprising them |
| 02/19/2003 | CN1101811C Pictest-spengler reaction for synthesis of tetrahydroisoquinolines and related heterocyclic compounds |
| 02/18/2003 | US6521757 Preparation of fused polycyclic alkaloids by ring closure of azomethine ylides, novel compounds thereof and their use as chemotherapeutic agents |
| 02/13/2003 | WO2003011829A1 Process for the production of quinazolines |
| 02/13/2003 | WO2003011812A1 NOVEL AMINE DERIVATIVE HAVING HUMAN β-TRYPTASE INHIBITORY ACTIVITY AND DRUGS CONTAINING THE SAME |
| 02/13/2003 | US20030032652 Hydroxamic and carboxylic acid derivatives |
| 02/13/2003 | CA2456096A1 Novel amine derivative having human .beta.-tryptase inhibitory activity and medecine containing the same |
| 02/13/2003 | CA2451075A1 Process for the production of quinazolines |
| 02/12/2003 | EP1282600A1 Inhibitors of dipeptidyl peptidase iv |
| 02/12/2003 | CN1396833A Integrin expression inhibitors |
| 02/12/2003 | CN1396156A Process for effectively purifying isoquinoline |
| 02/12/2003 | CN1101190C HIV protease inhibitor combination medicine |
| 02/11/2003 | US6518310 Non-peptidic; inhibits trypsin-like protease, thrombin and embolus formation; anticoagulant |
| 02/11/2003 | US6518286 Compounds |
| 02/11/2003 | US6518283 Squaric acid derivatives |
| 02/11/2003 | US6518272 HT3 receptor agonists and antagonists; treatment of anxiety, depression, cognitive deficits, and prostate cancer |
| 02/06/2003 | WO2003010230A1 Method of mass-colouring synthetic materials |
| 02/06/2003 | WO2002046172A3 Substituted 1, 3, 5-triazines and pyrimidines as abca-1 elevating compounds against coronary artery disease or atherosclerosis |
| 02/06/2003 | WO2002046141A3 Coumpounds of the formula r1-x-y-z-nr2r3 as abca-1 elevating agents against coronary artery disease or atherosclerosis |
| 02/06/2003 | US20030027836 Arylalkoxy-substituted tetrahydroisoquinoline-3-carboxylic acids or esters |
| 02/06/2003 | US20030027832 4-Phenyl-1-piperazinyl, -piperidinyl and -tetrahydropyridyl derivatives |
| 02/06/2003 | US20030027812 Useful for treating or preventing a disorder or condition selected from hypertension, depression, anxiety, phobias, post trauma stress, sexual disfunction, eating disorder, obesity, Alzheimer's disease, Parkinson's disease etc. |
| 02/06/2003 | US20030027807 Vitronectin receptor antagonists, their preparation and their use |
| 02/06/2003 | CA2454903A1 Substituted piperazines as modulators of the melanocortin receptor |
| 02/05/2003 | EP1280800A1 N-sulfonyl hydroxamic acid derivatives as inhibitors of cd 23 |
| 02/05/2003 | EP1280777A1 Tetrahydroisoquinoline analogs useful as growth hormone secretagogues |
| 02/05/2003 | EP1280776A1 Substituted benzoic acid amides and use thereof for the inhibition of angiogenesis |
| 02/05/2003 | EP1280765A2 Fluorous tagging compounds and their use |
| 02/05/2003 | EP1086078B1 Neuropeptide y5 receptor antagonists |
| 02/05/2003 | EP0848706B1 Substituted benzene-fused heterocyclics as neurokinin antagonists |
| 02/05/2003 | CN1395562A Nitrogenous cyclic compounds and pharmaceutical compositions containing the same |
| 02/04/2003 | US6515155 Group 4 metal complexes of the constrained geometry type, catalysts derived therefrom and polymerization processes using the same, characterized by a nitrogen containing aliphatic or cycloaliphatic moiety that is substituted with one or more |
| 02/04/2003 | US6515129 A pharmaceutical composition which comprises, a cyclic imide derivative represented by the general formula (I): present invention relates to an aminopeptidase N inhibitor or an angiogenesis inhibitor, modulates production of tumor necrosis |
| 02/03/2003 | WO2002016312A2 Novel compounds inhibiting factor xa activity |
| 02/03/2003 | CA2418283A1 Novel compounds inhibiting factor xa activity |